Epizyme Operating Expenses 2011-2025 | EPZM

Annual Operating Expenses Epizyme

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	236 M	201 M	150 M	147 M	120 M	135 M	96.5 M	71.6 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
236 M	71.6 M	145 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Arbutus Biopharma Corporation ABUS	96.2 M	$ 4.79	2.57 %	$ 795 M	Canada
Aclaris Therapeutics ACRS	92.7 M	$ 3.39	1.02 %	$ 262 M	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	141 M	-	-15.15 %	$ 60.3 M	Britain
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Aeglea BioTherapeutics AGLE	209 M	-	-	$ 1.01 B	USA
Ascendis Pharma A/S ASND	338 M	$ 213.61	1.64 %	$ 5 B	Danmark
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Aptorum Group Limited APM	20.7 M	$ 1.32	-0.75 %	$ 7.2 M	China
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.39	-0.88 %	$ 8.16 B	Australia
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
AstraZeneca PLC AZN	17.6 B	$ 89.7	-0.64 %	$ 96.9 B	Britain
Amphastar Pharmaceuticals AMPH	168 M	$ 25.67	-0.87 %	$ 1.24 B	USA
Anika Therapeutics ANIK	51.6 M	$ 9.55	0.63 %	$ 140 M	USA
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	28.5 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	152 M	-	-7.31 %	$ 87 M	USA
Aytu BioScience AYTU	53.7 M	$ 2.33	2.19 %	$ 14.6 M	USA
Arena Pharmaceuticals ARNA	427 M	-	-6.81 %	$ 3.04 B	USA
Baudax Bio BXRX	54.6 M	-	0.59 %	$ 63 K	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
ChromaDex Corporation CDXC	53.9 M	-	-0.88 %	$ 598 M	USA
Axon Enterprise AXON	1.18 B	$ 573.02	-1.38 %	$ 43.4 B	USA
Checkpoint Therapeutics CKPT	56.2 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	23.4 M	-	-16.75 %	$ 25.8 M	USA
Clovis Oncology CLVS	425 M	-	-7.23 %	$ 13 M	USA
Biogen BIIB	5.39 B	$ 174.8	1.33 %	$ 25.5 B	USA
BioVie BIVI	18.1 M	$ 1.52	0.33 %	$ 2.25 M	USA
Cortexyme CRTX	34.6 M	-	-1.05 %	$ 67.1 M	USA
Deciphera Pharmaceuticals DCPH	226 M	-	-	$ 2.18 B	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	1.07 B	$ 11.54	0.87 %	$ 746 M	USA
Benitec Biopharma BNTC	9.83 M	$ 12.57	-3.01 %	$ 517 M	USA
BioNTech SE BNTX	512 M	$ 95.76	-0.25 %	$ 27.2 B	Germany
Eloxx Pharmaceuticals ELOX	34.4 M	-	-5.68 %	$ 8.28 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 0.29	-1.45 %	$ 631 M	Israel
Catalyst Biosciences CBIO	176 M	$ 15.4	0.59 %	$ 1.01 B	USA
Enochian Biosciences ENOB	189 M	-	-	$ 40.5 M	USA
Cerus Corporation CERS	135 M	$ 2.22	3.02 %	$ 410 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Burford Capital Limited BUR	106 M	$ 9.24	1.04 %	$ 1.52 B	Britain